Antiviral Activity of Ergoferon against Group A Rotavirus


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.

Sobre autores

A. Emelianova

Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology

Autor responsável pela correspondência
Email: agemelianova@gmail.com
Rússia, Moscow

I. Shilovskii

State Research Center Institute of Immunology, Federal Medical-Biological Agency

Email: agemelianova@gmail.com
Rússia, Moscow

M. Sundukova

State Research Center Institute of Immunology, Federal Medical-Biological Agency

Email: agemelianova@gmail.com
Rússia, Moscow

M. Khaitov

State Research Center Institute of Immunology, Federal Medical-Biological Agency

Email: agemelianova@gmail.com
Rússia, Moscow

O. Epshtein

Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology

Email: agemelianova@gmail.com
Rússia, Moscow

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media New York, 2016